| Literature DB >> 34473729 |
Jing Zhang1,2, Zhou-Tao Pei1,2, Ya-Ni Zhao3, Meng Zhang1,2, Li-Ling Zhang1,2, Wen-Qiang Wang1,2, Jing-Ya Wu1,2, Ran Yu1,2, Li-Wei Sun1,2.
Abstract
Benzophenone (BPs) and 4-Methylbenzylidene Camphor are used as ultraviolet (UV) filters to protect the skin and hair in personal care products. The discharging of the three chemicals may endanger the receiving water ecosystem. In the present study, the mutagenicity of BP-6, BP-8, and 4-Methylbenzylidene Camphor was tested using the Salmonella typhimurium reverse mutation test (Ames test) in the system with and without rat liver microsomal preparations (S9). Four S.typhimurium strains, TA97, TA98, TA100, and TA102 were employed in the Ames tests. The mutagenicity was detected from all three chemicals. The addition of S9 increased the mutation ratios of three chemicals to four strains, except BP-6 to TA100 strain and 4-MBC to TA97 and TA98 strain. In the mixed experiment, all positive effects were detected in the absence of S9. However, the results all became negative in the presence of S9. For the mixture of BP-6 and 4-MBC, positive results were detected on four tester strains except for the TA100 strain. For the mixture of BP-6, BP-8, and 4-MBC, positive results were detected on four strains. The mixture test results showed antagonism in mutagenicity for the mixture of BP-6 and 4-MBC to TA98 and TA100 strains and the mixture of BP-6, BP-8, and 4-MBC to TA100 and TA102 strains.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34473729 PMCID: PMC8412341 DOI: 10.1371/journal.pone.0255504
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Reverse mutation colonies of four S. typhimurium strains exposed to BP-6 with and without S9.
| Chemicals | Dose (μg/plate) | TA97 | TA98 | TA100 | TA102 | ||||
|---|---|---|---|---|---|---|---|---|---|
| -S9 | +S9 | -S9 | +S9 | -S9 | +S9 | -S9 | +S9 | ||
| DMSO | 100 | 123±10 | 134±12 | 48±5 | 31±3 | 197±15 | 122±10 | 319±7 | 226±19 |
| 0 | 168±13 | 156±9 | 33±4 | 34±3 | 184±5 | 143±4 | 289±7 | 226±9 | |
| BP-6 | 0.5 |
|
| 54±3 |
| 206±4 | 233±9 | 325±6 |
|
| 5 | 172±14 |
| 27±1 |
| 123±11 | 223±23 | 404±14 |
| |
| 50 | 170±9 |
| 24±3 |
|
| 214±11 | 391±16 | 414±12 | |
| 500 | 184±13 |
| 48±4 |
| 137±12 | 205±15 | 344±14 | 433±7 | |
| 2500 | 166±7 | 209±8 | 39±2 |
| 125±10 | 234±9 | 344±14 |
| |
* MR ≥ 2 compared to control.
Reverse mutation colonies of four S. typhimurium strains exposed to 4-MBC with and without S9.
| Chemicals | Dose (μg/plate) | TA97 | TA98 | TA100 | TA102 | ||||
|---|---|---|---|---|---|---|---|---|---|
| -S9 | +S9 | -S9 | +S9 | -S9 | +S9 | -S9 | +S9 | ||
| DMSO | 100 | 123±10 | 134±12 | 48±5 | 31±3 | 197±15 | 122±10 | 319±7 | 226±19 |
| 0 | 168±13 | 156±9 | 33±4 | 34±3 | 184±5 | 143±4 | 289±7 | 226±9 | |
| 4-MBC | 0.5 |
|
|
|
| 161±13 | 219±6 | 342±23 |
|
| 5 |
|
|
|
| 117±13 | 203±19 | 366±7 |
| |
| 50 |
|
| 48±6 |
| 217±18 | 193±11 |
| 320±7 | |
| 500 | 177±18 | 187±5 | 52±3 | 53±3 | 4 | 225±17 | 231±12 |
| |
| 2500 | 49±3 | 187±1 | 6 | 39±1 | 0 | 202±10 | 301±17 | 345±15 | |
* MR ≥ 2 compared to control.
Fig 1Mutagenesis of BP-6 to four strains in the presence and absence of S9 liver extract; (a) TA97 strain; (b) TA98 strain; (c) TA100 strain; (d) TA102 strain.
The mutation ratio (MR) is the average ratio (±SE) from three parallel plates.
Fig 3Mutagenesis of 4-MBC to four strains in the presence and absence of S9 liver extract; (a) TA97 strain; (b) TA98 strain; (c) TA100 strain; (d) TA102 strain.
The mutation ratio (MR) is the average ratio (±SE) from three parallel experiments.
Reverse mutation colonies of four S. typhimurium strains exposed to BP-8 with and without S9.
| Chemicals | Dose (μg/plate) | TA97 | TA98 | TA100 | TA102 | ||||
|---|---|---|---|---|---|---|---|---|---|
| -S9 | +S9 | -S9 | +S9 | -S9 | +S9 | -S9 | +S9 | ||
| DMSO | 100 | 123±10 | 134±12 | 48±5 | 31±3 | 197±15 | 122±10 | 319±7 | 226±19 |
| 0 | 168±13 | 156±9 | 33±4 | 34±3 | 184±5 | 143±4 | 289±7 | 226±9 | |
| BP-8 | 0.5 | 283±20 | 288±8 |
|
| 169±15 | 228±14 | 304±21 |
|
| 5 |
|
|
|
| 146±14 | 221±17 | 373±18 |
| |
| 50 | 175±16 |
|
|
| 123±12 | 242±17 | 367±20 | 448±14 | |
| 500 | 204±5 |
|
| 41±5 | 107±10 | 167±4 | 387±20 | 354±13 | |
| 2500 | 22±3 | 0 | 3 | 0 | 0 | 0 |
|
| |
* MR ≥ 2 compared to control.
Fig 2Mutagenesis of BP-8 to four strains in the presence and absence of S9 liver extract; (a) TA97 strain; (b) TA98 strain; (c) TA100 strain; (d) TA102 strain.
The mutation ratio (MR) is the average ratio (±SE) from three parallel experiments.
Reverse mutation colonies of four S. typhimurium strains exposed to mixtures of BP-6 and 4-MBC with and without S9.
| Chemicals | Dose (percentage) | TA97 | TA98 | TA100 | TA102 | ||||
|---|---|---|---|---|---|---|---|---|---|
| -S9 | +S9 | -S9 | +S9 | -S9 | +S9 | -S9 | +S9 | ||
| DMSO | 100 | 123±10 | 134±12 | 48±5 | 31±3 | 197±15 | 122±10 | 319±7 | 226±19 |
| 0 | 168±13 | 156±9 | 33±4 | 34±3 | 184±5 | 143±4 | 289±7 | 226±9 | |
| BP-6 + 4-MBC | 0.10% | 281±19 | 242±6 | 68±6 |
| 260±5 | 245±8 | 284±16 | 373±13 |
| 1.00% |
| 200±7 | 72±4 | 53±4 | 380±27 | 208±4 | 312±18 | 349±10 | |
| 10.00% | 253±24 | 160±4 | 41±2 | 62±2 | 133±7 | 203±11 |
| 331±6 | |
| 50.00% | 153±13 | 153±5 |
| 50±5 | 182±11 | 183±2 |
| 394±3 | |
| 100.00% |
| 153±3 | 0 | 47±5 | 2 | 175±5 | 323±24 | 391±11 | |
* MR ≥ 2 compared to control.
Reverse mutation colonies of four S. typhimurium strains exposed to mixtures of BP-6, BP-8, and 4-MBC with and without S9.
| Chemicals | Dose (percentage) | TA97 | TA98 | TA100 | TA102 | ||||
|---|---|---|---|---|---|---|---|---|---|
| -S9 | +S9 | -S9 | +S9 | -S9 | +S9 | -S9 | +S9 | ||
| DMSO | 100 | 123±10 | 134±12 | 48±5 | 31±3 | 197±15 | 122±10 | 319±7 | 226±19 |
| 0 | 168±13 | 156±9 | 33±4 | 34±3 | 184±5 | 143±4 | 289±7 | 226±9 | |
| BP-6+BP-8 + 4-MBC | 0.10% |
| 240±4 | 78±4 | 63±5 |
| 207±8 | 310±10 | 363±13 |
| 1.00% |
| 195±6 |
| 53±4 | 13 | 233±8 | 301±16 | 400±7 | |
| 10.00% |
| 160±4 | 54±2 | 50±3 | 0 | 201±10 | 287±11 | 395±10 | |
| 50.00% |
| 131±8 | 5 | 48±4 | 0 | 175±2 |
| 356±12 | |
| 100.00% |
| 164±4 | 13 | 63±4 | 5 | 122±2 |
| 292±12 | |
* MR ≥ 2 compared to control.
Fig 4Mutagenesis of mixtures of BP-6 and 4-MBC to four strains in the presence and absence of S9 liver extract; (a) TA97 strain; (b) TA98 strain; (c) TA100 strain; (d) TA102 strain.
The mutation ratio (MR) is the average ratio (±SE) from three parallel experiments.
Fig 5Mutagenesis of mixtures of BP-6, BP-8, and 4-MBC to four strains in the presence and absence of S9 liver extract; (a) TA97 strain; (b) TA98 strain; (c) TA100 strain; (d) TA102 strain.
The mutation ratio (MR) is the average ratio (±SE) from three parallel experiments.